Inspire Medical Systems, Inc. (INSP) Dividend History

Inspire Medical Systems, Inc. develops and commercializes medical devices for the treatment of sleep apnea. The company's flagship device, the Inspire Therapy system, uses neurostimulation technology to stimulate the hypoglossal nerve, helping to keep the airway open during sleep. Founded in 2007 and headquartered in Minneapolis, Minnesota, Inspire aims to provide an alternative to traditional sleep apnea treatments such as CPAP machines.

5500 Wayzata Blvd, Golden Valley, MN, 55416
Phone: 763-957-5037
Website: https://www.inspiresleep.com

Dividend History

Inspire Medical Systems, Inc. currently does not pay dividends

Company News

Inspire Medical's Earnings Surge in Q4

Inspire Medical Systems, a leader in neurostimulation technology for sleep apnea, reported strong Q4 results with a 24.5% revenue increase and a 243% jump in operating income. The company is focused on expanding its geographical reach and product offerings, with the upcoming launch of its Inspire V device.

The Motley Fool
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

Inspire Medical Systems, a medical technology company focused on obstructive sleep apnea solutions, announced that it will present at the Jefferies London Healthcare Conference on November 20, 2024.

GlobeNewswire Inc.
Inspire Medical Systems, Inc. to Present at UBS Global Healthcare Conference

Inspire Medical Systems, a medical technology company focused on obstructive sleep apnea solutions, announced that it will present at the UBS Global Healthcare Conference on November 13, 2024.

GlobeNewswire Inc.
Inspire Medical Systems, Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024

Inspire Medical Systems, Inc. (NYSE: INSP) will release its Q3 2024 financial results on November 4, 2024, and host a conference call to discuss the results and recent business developments.

GlobeNewswire Inc.
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval - Zacks Investment Research

Inspire Medical Systems has received CE mark certification for its Inspire therapy under the European Union's Medical Device Regulation (EU MDR), which is a significant milestone for the company's expansion in the global obstructive sleep apnea treatment market.

Zacks Investment Research

Featured Companies: BSX GMED SYK

Dividend data last updated 06/06/2025 23:12:09 UTC